DrugPatentWatch Database Preview
POLYMYXIN B SULFATE - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for polymyxin b sulfate and what is the scope of patent protection?
Polymyxin b sulfate
is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Mylan Asi, West-ward Pharms Int, Xellia Pharms Aps, Xgen Pharms, X Gen Pharms, Paddock Llc, Allergan, Akorn Inc, Bausch And Lomb, and Sandoz Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.There are twelve drug master file entries for polymyxin b sulfate. Six suppliers are listed for this compound.
Summary for POLYMYXIN B SULFATE
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 14 |
| NDAs: | 14 |
| Drug Master File Entries: | 12 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Clinical Trials: | 4 |
| Patent Applications: | 2 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in POLYMYXIN B SULFATE? | POLYMYXIN B SULFATE excipients list |
| DailyMed Link: | POLYMYXIN B SULFATE at DailyMed |
Recent Clinical Trials for POLYMYXIN B SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| DongGuk University | N/A |
| Azidus Brasil | Phase 3 |
| Chulalongkorn University | Phase 3 |
Pharmacology for POLYMYXIN B SULFATE
| Drug Class | Polymyxin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for POLYMYXIN B SULFATE
US Patents and Regulatory Information for POLYMYXIN B SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn Inc | TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE | polymyxin b sulfate; trimethoprim sulfate | SOLUTION/DROPS;OPHTHALMIC | 065006-001 | Dec 17, 1998 | AT | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| Gland Pharma Ltd | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 207322-001 | Apr 14, 2016 | AP | RX | No | Yes | Get Started Free | Get Started Free | Get Started Free | |||
| West-ward Pharms Int | POLYMYXIN B SULFATE | polymyxin b sulfate | INJECTABLE;INJECTION | 060716-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Get Started Free | Get Started Free | Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
